Body weight, hemoglobin, and absolute neutrophil count in patients with advanced-stage epithelial ovarian cancer who received chemotherapy: A single-center study

1st Physics and Technologies in Medicine and Dentistry Symposium

物理学;医药卫生

Gunawan, Y.^1 ; Winarto, H.^1

Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia^1

关键词: Body mass index;    Body weight;    Carboplatin;    Medical record;    Neutropenia;    Ovarian cancers;    Secondary datum;    Treatment modality;   

Others  :  https://iopscience.iop.org/article/10.1088/1742-6596/884/1/012029/pdf
DOI  :  10.1088/1742-6596/884/1/012029

学科分类：卫生学

来源: IOP

【 摘 要 】

The side effects of chemotherapy, a treatment modality of ovarian cancer, can disrupt overall treatment. To date, the clinical and laboratory profiles of ovarian cancer patients during chemotherapy have not been investigated. This study aimed to elucidate the clinical and laboratory profiles of patients with advanced-stage epithelial ovarian cancer who received chemotherapy in Dr. Cipto Mangunkusumo Hospital, including body mass index (BMI), hemoglobin (Hb), and absolute neutrophil count (ANC). To generate these clinical and laboratory profiles, we collected secondary data from the medical records of advanced-stage epithelial ovarian cancer patients who received six cycles of carboplatin and paclitaxel chemotherapy. We enrolled 23 patients with advanced-stage epithelial ovarian cancer patients who received six cycles of chemotherapy. Mean patient BMI before and after chemotherapy was 22.86 kg/m2and 21.78 kg/m2, respectively. Hb levels before chemotherapy were 8-13 g/dl, with Hb